C5AR1 and neurodegenerative disease: Among the complement activation effector molecules, C5a is considered the most potent peptide, with its signalling through its main receptor C5aR1 having detrimental effects in multiple neurodegenerative diseases, including ALS [9, 10, 12, 26, 27].